troglitazone has been researched along with Proteinuria in 5 studies
Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.
Proteinuria: The presence of proteins in the urine, an indicator of KIDNEY DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Troglitazone attenuated HOMA-IR and ameliorated proteinuria, but did not affect body weight, creatinine clearance, or blood pressure." | 3.73 | Insulin resistance contributes to obesity-related proteinuria. ( Iwasawa, H; Matsumoto, H; Nagaoka, Y; Nakao, T; Okada, T; Tomaru, R; Wada, T, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haraguchi, K | 1 |
| Shimura, H | 1 |
| Onaya, T | 1 |
| Matsumoto, H | 1 |
| Nakao, T | 1 |
| Okada, T | 1 |
| Nagaoka, Y | 1 |
| Iwasawa, H | 1 |
| Tomaru, R | 1 |
| Wada, T | 1 |
| Ogawa, M | 1 |
| Hirawa, N | 1 |
| Tsuchida, T | 1 |
| Eguchi, N | 1 |
| Kawabata, Y | 1 |
| Numabe, A | 1 |
| Negoro, H | 1 |
| Hakamada-Taguchi, R | 1 |
| Seiki, K | 1 |
| Umemura, S | 1 |
| Urade, Y | 1 |
| Uehara, Y | 1 |
| Fujiwara, K | 1 |
| Hayashi, K | 1 |
| Ozawa, Y | 1 |
| Tokuyama, H | 1 |
| Nakamura, A | 1 |
| Saruta, T | 1 |
| Yoshida, K | 1 |
| Kohzuki, M | 1 |
| Xu, HL | 1 |
| Wu, XM | 1 |
| Kamimoto, M | 1 |
| Sato, T | 1 |
5 other studies available for troglitazone and Proteinuria
| Article | Year |
|---|---|
Suppression of experimental crescentic glomerulonephritis by peroxisome proliferator-activated receptor (PPAR)gamma activators.
Topics: Animals; Anti-Glomerular Basement Membrane Disease; Antibodies; Autoantibodies; CD8-Positive T-Lymph | 2003 |
Insulin resistance contributes to obesity-related proteinuria.
Topics: Adult; Biopsy; Blood Glucose; Blood Pressure; Body Mass Index; Chromans; Creatinine; Female; Follow- | 2005 |
Urinary excretions of lipocalin-type prostaglandin D2 synthase predict the development of proteinuria and renal injury in OLETF rats.
Topics: Animals; Chromans; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Hypoglycemic Agents; Immunoenz | 2006 |
Renal protective effect of troglitazone in Wistar fatty rats.
Topics: Animals; Blood Pressure; Body Weight; Chromans; Female; Hypoglycemic Agents; Insulin Resistance; Kid | 2000 |
Effects of troglitazone and temocapril in spontaneously hypertensive rats with chronic renal failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Chromans; Humans; Hypertension; H | 2001 |